Myomo reports Q2 GAAP EPS of -$0.07 and revenue of $10.1M, exceeding analyst expectations by $0.04 and $0.86M respectively.
Myomo reported a second-quarter GAAP loss per share of $0.07, narrower than the anticipated loss by $0.04. Revenue reached $10.1M, surpassing estimates by $0.86M.
Analysts had projected a larger loss and lower revenue for the quarter. The company’s performance reflects improved operational efficiency and stronger demand for its medical devices.
Shares showed limited movement in after-hours trading as investors digested the results.